Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $615.03 million. The enterprise value is $245.29 million.

Market Cap	615.03M
Enterprise Value	245.29M

Important Dates

The next estimated earnings date is Monday, August 5, 2024, after market close.

Earnings Date	Aug 5, 2024
Ex-Dividend Date	n/a

Share Statistics

ATXS has 54.91 million shares outstanding. The number of shares has increased by 87.14% in one year.

Shares Outstanding	54.91M
Shares Change (YoY)	+87.14%
Shares Change (QoQ)	+73.60%
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	105.15%
Float	31.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.67
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 33.83, with a Debt / Equity ratio of 0.00.

Current Ratio	33.83
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.80% and return on invested capital (ROIC) is -25.47%.

Return on Equity (ROE)	-32.80%
Return on Assets (ROA)	-31.60%
Return on Capital (ROIC)	-25.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.02% in the last 52 weeks. The beta is 0.74, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+19.02%
50-Day Moving Average	9.56
200-Day Moving Average	9.31
Relative Strength Index (RSI)	64.57
Average Volume (20 Days)	512,002

Short Selling Information

The latest short interest is 4.24 million, so 7.73% of the outstanding shares have been sold short.

Short Interest	4.24M
Short Previous Month	4.15M
Short % of Shares Out	7.73%
Short % of Float	13.55%
Short Ratio (days to cover)	8.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.69M
Pretax Income	-81.63M
Net Income	-81.63M
EBITDA	-81.63M
EBIT	-81.63M
Earnings Per Share (EPS)	-$2.40

Full Income Statement

Balance Sheet

The company has $369.91 million in cash and $168,000 in debt, giving a net cash position of $369.74 million or $6.73 per share.

Cash & Cash Equivalents	369.91M
Total Debt	168,000
Net Cash	369.74M
Net Cash Per Share	$6.73
Equity (Book Value)	367.74M
Book Value Per Share	6.70
Working Capital	363.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$74.29 million and capital expenditures -$20,000, giving a free cash flow of -$74.31 million.

Operating Cash Flow	-74.29M
Capital Expenditures	-20,000
Free Cash Flow	-74.31M
FCF Per Share	-$1.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.14%
Shareholder Yield	-87.14%
Earnings Yield	-13.27%
FCF Yield	-12.08%

Analyst Forecast

The average price target for ATXS is $22.50, which is 100.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.50
Price Target Difference	100.89%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 1:6.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	2